| P2093 | author name string | Philip N Hineline | |
| | Ellen A Walker | |
| | Emily B Bisen-Hersh | |
| P2860 | cites work | Treating childhood acute lymphoblastic leukemia without cranial irradiation | Q24644599 |
| | CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory | Q28215988 |
| | Neurocognitive sequelae of childhood cancers and their treatment | Q28240816 |
| | Neurocognitive effects of treatment for childhood cancer | Q28270213 |
| | Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens | Q28318513 |
| | The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia | Q28319573 |
| | Cancer chemotherapy impairs contextual but not cue-specific fear memory | Q30438754 |
| | Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. | Q30499383 |
| | Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone | Q31397974 |
| | The behavioral neurology of cerebral white matter | Q32060580 |
| | Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study | Q33262846 |
| | The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice | Q33703348 |
| | Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers | Q33915042 |
| | Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial | Q33988480 |
| | Attention and working memory abilities in children treated for acute lymphoblastic leukemia | Q34159130 |
| | IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice | Q34508233 |
| | The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice | Q48436186 |
| | Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate | Q48442432 |
| | Unilateral hippocampal lesions in newborn and adult rats: effects on spatial memory and BDNF gene expression | Q48469024 |
| | A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. | Q48491143 |
| | Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia | Q48564442 |
| | Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). II. The influence on the seizure activity and the learning and memory processes in mice | Q48724694 |
| | An animal model to detect learning deficits following treatment of the immature brain. Studies using radiation and methotrexate. | Q48812712 |
| | Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae | Q48825976 |
| | Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study | Q49107769 |
| | Screening for neurocognitive impairment in pediatric cancer long-term survivors | Q50122627 |
| | Late effects in survivors of infant leukemia. | Q50495206 |
| | Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. | Q50529998 |
| | Impact of acute lymphoblastic leukemia therapy on attention and working memory in children. | Q51030080 |
| | Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. | Q51929727 |
| | Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice | Q52051472 |
| | Visual attention in long-term survivors of leukemia receiving cranial radiation therapy. | Q52092275 |
| | [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood] | Q52184398 |
| | Methotrexate does not interfere with an appetitive Pavlovian conditioning task in Sprague-Dawley rats. | Q52204989 |
| | An animal model to detect the neuropsychological toxicity of anticancer agents. | Q52248003 |
| | Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. | Q53226410 |
| | The effect of methotrexate on the development of synapses in the neonatal rat hippocampus | Q69419745 |
| | The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia | Q72010773 |
| | Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer | Q72684562 |
| | Effect of chronic vincristine treatment on mechanical withdrawal response and pre-pulse inhibition in the rat | Q80199666 |
| | Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat | Q81249270 |
| | Chronic health conditions in adult survivors of childhood cancer | Q34573463 |
| | Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. | Q35121761 |
| | Attentional ability among survivors of leukaemia | Q35262843 |
| | Academic career after treatment for acute lymphoblastic leukaemia | Q35266424 |
| | Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory | Q35686715 |
| | Candidate mechanisms for chemotherapy-induced cognitive changes | Q35898051 |
| | CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. | Q36023980 |
| | Treatment of acute lymphoblastic leukemia | Q36366185 |
| | A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia | Q36455459 |
| | Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? | Q36458593 |
| | Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Questionnaire | Q36953040 |
| | CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects? | Q37151163 |
| | Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment | Q37299467 |
| | Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. | Q37334833 |
| | Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. | Q37342934 |
| | Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. | Q37474408 |
| | Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research | Q37792336 |
| | Neurotoxicity due to central nervous system therapy for childhood leukemia | Q38623815 |
| | Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. | Q39787583 |
| | Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. | Q40433364 |
| | Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia | Q40552600 |
| | Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy | Q41733456 |
| | A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities | Q42218632 |
| | Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil | Q43242123 |
| | Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. | Q43258716 |
| | Tamoxifen and toremifene cause impairment of learning and memory function in mice | Q43867271 |
| | Hippocampal brain amines in methotrexate-induced learning and memory deficit | Q44254470 |
| | Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study | Q44907709 |
| | Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats | Q44940392 |
| | Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity. | Q46018178 |
| | Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis. | Q46069525 |
| | Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats | Q46405413 |
| | A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation | Q46698085 |
| | Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors | Q46836494 |
| | Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. | Q46923027 |
| | Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial | Q48136066 |
| | MRI morphometry of mamillary bodies, caudate nuclei, and prefrontal cortices after chemotherapy for childhood leukemia: multivariate models of early and late developing memory subsystems | Q48139069 |
| | Spatial learning deficits in rats after injection of vincristine into the dorsal hippocampus | Q48172675 |
| | Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia | Q48181584 |
| | Postirradiation treatment outcomes for children with acute lymphocytic leukemia: clarification of risks | Q48213518 |
| | Systemic administration of doxorubicin impairs aversively motivated memory in rats. | Q48257834 |
| | Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors | Q48317157 |
| | Treatment-related white matter changes in cancer patients | Q48354691 |
| P921 | main subject | chemotherapy | Q974135 |
| | leukemia | Q29496 |
| | lymphoblastic leukemia | Q18553852 |
| P304 | page(s) | 292-301 | |
| P577 | publication date | 2011-05-19 | |
| P1433 | published in | Journal of Cancer | Q6294901 |
| P1476 | title | Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models | |
| P478 | volume | 2 | |